Frazier Healthcare Partners takes majority stake in bioengineering firm Atum

The Newark, California-based company combines machine learning, gene synthesis and cell line development to help biopharma companies bring new therapies to the clinic.

13 minutes ago•1 min read
LinkedInXEmail
LinkedInXEmail

Related articles